PHASE I TRIALS FOR PSORAXINE

Article

Astralis has begun Phase I clinical trial for Psoraxine for the treatment of moderate plaque psoriasis.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.